Glucagon receptor — Drug Target
All drugs that target Glucagon receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
Antihypoglycemic Agent [EPC] · Glucagon receptor antagonist · Glucagon receptor agonist
Marketed (1)
- Zegalogue · Zealand Pharma · Antihypoglycemic Agent [EPC] · Metabolic
Zegalogue works by stimulating the release of glucose from stored energy sources in the body.
Phase 3 pipeline (3)
- GZR4 Injection · Gan and Lee Pharmaceuticals, USA · Glucagon receptor antagonist · Diabetes
GZR4 Injection is a glucagon receptor antagonist. - MK-0524B · Merck Sharp & Dohme LLC · Glucagon receptor antagonist · Diabetes
MK-0524B is a glucagon receptor antagonist. - MK-1293 · Merck Sharp & Dohme LLC · Glucagon receptor antagonist · Diabetes
MK-1293 is a glucagon receptor antagonist.
Phase 2 pipeline (9)
- ARA 290 · Claes-Göran Östenson · Glucagon receptor antagonist · Diabetes
ARA 290 is a peptide that acts as a glucagon receptor antagonist. - CELSIOR® group · Hospices Civils de Lyon · Glucagon receptor agonist · Diabetes
CELSEOR is a glucagon receptor agonist. - JNJ16269110 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Glucagon receptor antagonist · Diabetes
JNJ16269110 is a selective and potent antagonist of the human glucagon receptor. - AGN-195263 0.03% · Allergan · Glucagon receptor antagonist · Diabetes
AGN-195263 is a glucagon receptor antagonist. - AP1189 · SynAct Pharma Aps · Glucagon receptor agonist · Diabetes
AP1189 is a glucagon receptor agonist. - ABT-288 High Dose · AbbVie (prior sponsor, Abbott) · Glucagon receptor antagonist · Diabetes
ABT-288 High Dose is a glucagon receptor antagonist. - ATL-962 · Alizyme · Glucagon receptor antagonist · Diabetes
ATL-962 is a glucagon receptor antagonist. - GW642444 6.25 · GlaxoSmithKline · Glucagon receptor antagonist · Diabetes
GW642444 is a glucagon receptor antagonist. - ATL-104 · Alizyme · Glucagon receptor antagonist · Diabetes
ATL-104 is a glucagon receptor antagonist.